XML 26 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings per share
 3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings per share Earnings per share
The Company is required to present basic earnings per share and diluted earnings per share in its Consolidated Statements of Operations. Basic earnings per share amounts are computed by dividing net income by the weighted average number of shares of common stock outstanding. Diluted earnings per share reflects additional shares of common stock that would have been outstanding if potentially dilutive shares of common stock had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential shares of common stock that may be issued by the Company relate to outstanding unvested RSAs granted to directors and employees. The dilutive effect resulting from these potential shares is determined using the treasury stock method. The Company is also required to provide a reconciliation of the numerator and denominator used in the computation of both basic and diluted earnings per share.
The following table summarizes the computation of basic and diluted earnings per share for the three months ended March 31, 2024 and 2023:
(Net loss in thousands)Three Months Ended March 31,
20242023
Basis loss per share:
Net loss attributable to Common shareholders$(299)$(699)
Divided by:
Weighted average shares outstanding3,976,0733,965,186
Basic loss per share of common stock$(0.08)$(0.18)
Diluted loss per share:
Net loss attributable to Common shareholders$(299)$(699)
Weighted average shares outstanding3,976,0733,965,186
Effect of potentially dilutive restricted shares of common stock— (1)— (2)
Divided by:
Weighted average diluted shares outstanding3,976,0733,965,186
Diluted loss per share of common stock$(0.08)$(0.18)
(1)
The weighted average diluted shares outstanding does not include 22,269 anti-dilutive restricted shares of common stock for the three months ended March 31, 2024.
(2)
The weighted average diluted shares outstanding does not include 491 anti-dilutive restricted shares of common stock for the three months ended March 31, 2023.